PanGIA Biotech, Inc. ("PanGIA") announced a peer-reviewed clinical study published in Diagnostics, "Urine-Based Machine Learning Assay Detects Prostate Cancer," (1) demonstrating clinical validation ...
The Gyne Cancer Company™ — today announced the publication of peer-reviewed evidence demonstrating that molecular signals ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient’s risk of hepatocellular carcinoma with high accuracy.
Partnership expands access to breakthrough blood-based cancer screening into Superpower's comprehensive health check and personalized plans. SAN FRANCISCO, April 1, 2026 /PRNewswire/ -- Superpower, ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
DELFI Diagnostics to showcase whole-genome cfDNA platform advances in cancer detection and monitoring at AACR 2026 meeting: Palo Alto, California Wednesday, April 8, 2026, 15:00 H ...
Pancreatic cancer rarely announces itself early. It often grows in deep tissue, causes vague symptoms, and reaches medical ...
IRVINE, Calif., April 7, 2026 /PRNewswire/ -- Helio Genomics, Inc., an AI-powered TechBio company focused on early cancer detection, today announced the appointment of John Doyle to its Board of ...
Artificial intelligence (AI) could help physicians determine if survivors of childhood cancer need extra support - and the more information included in AI prompting, the better its performance. This ...